Evidence Hub

Long non-coding RNAs as biomarkers for diagnosis and prognosis in HPV-associated cervical cancer: A systematic scoping review

Bilan F, Jafari B, Gharesouran J, Kiani Darabi AH, Tajeddini S, Rezazadeh M, Ghafouri-Fard S

Cancer treatment and research communications, 2026

220 participants

Abstract

Background: Long non-coding RNAs (lncRNAs) are emerging regulators of HPV-driven carcinogenesis with potential diagnostic and prognostic value in cervical cancer (CC). A contemporary synthesis of clinical and mechanistic evidence is necessary to prioritize candidates for translational development.

Methods: We conducted a systematic scoping review of studies assessing lncRNAs in HPV-associated CC. Searches across major databases yielded 556 records; after de-duplication (n = 220) and screening, 154 full texts were assessed, and 27 studies met the inclusion criteria. No formal quality or risk-of-bias assessment was performed, consistent with the scoping review framework. The extracted data included study identifiers, lncRNA identity, HPV association, sample type/size, expression in HPV-positive disease, diagnostic metrics (AUC/sensitivity/specificity), prognostic measures (survival statistics), and mechanistic findings.

Results: The 27 studies described 29 unique lncRNAs, which were upregulated in 75% and downregulated in 25% of the studies. Tissue-derived analyses predominated (21 studies), with cell line experiments in 13 studies and circulating assays in a minority (serum 3; plasma 2). Diagnostic performance was reported in 13/27 studies (∼48%), and prognostic associations were reported in 22/27 (∼81.5%). MALAT1 and GATA6-AS1 were each evaluated in two independent studies, whereas HOTAIR was investigated in two studies with different types of evidence. Mechanistic data…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free